Mr
Matthew
Dean

Trainee Patent Attorney

Manchester Office

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Matthew graduated from Newcastle University having obtained an MChem Master of Chemistry with study abroad. Matthew also studied at Ludwig-Maximilians-Universität München in Germany, specialising in improving the efficiency and intensity of OLED technology by designing a catalogue of novel tertiary phosphine ligands for coordination with cheaper, alternative metals, removing the need for reliance on rare earth metals. During his Masters studies, Matthew worked on researching a family of fluorophores known as Boranils, which are commonly used for imaging probes, fluorescent dyes and switches.

Since joining HGF in 2018 as a trainee patent attorney, Matthew has gained experience in patent drafting, prosecution and freedom-to-operate matters in a number of different areas of chemistry. His main focus of expertise is directed to materials chemistry and fluorescent technology but also has experience in pharmaceuticals and medical device technology.

Specialisms

  • Catalysis
  • Material science
  • Pharmaceutical technologies
  • Physical chemistry
  • Polymer chemistry

Industries

  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Packaging icon Packaging
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents

Qualifications

Trainee


MCHEM

MChem with study abroad

POSTGRADUATE DIPLOMA OR CERTIFICATE

PGCert Intellectual Property

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details
Event - 25th May 2021

IAM webinar: How to capitalise on the 5G healthcare revolution

HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.